Aldeyra Therapeutics to Participate in Upcoming Investor Conferences
LEXINGTON, Mass.--(BUSINESS WIRE)--Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases, today announced that Todd C. Brady, M.D., Ph.D., President and CEO of Aldeyra, will participate in the following investor conferences in September: Citi’s 14th Annual Biotech Conference Four Seasons Hotel Boston, Mass. Thursday, September 5, 2019 BioCentu